These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 9822354)

  • 1. Comparative effectiveness of ceftriaxone in combination with a macrolide compared with ceftriaxone alone for pediatric patients hospitalized with community-acquired pneumonia.
    Leyenaar JK; Shieh MS; Lagu T; Pekow PS; Lindenauer PK
    Pediatr Infect Dis J; 2014 Apr; 33(4):387-92. PubMed ID: 24168982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decision analysis modelling of costs and outcomes following cefepime monotherapy in Canada.
    Halpern MT; Brown RE; Drolet M; Sorensen SV; Mandell LA
    Can J Infect Dis; 1997 Jan; 8(1):19-27. PubMed ID: 22514473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost of care and antibiotic prescribing attitudes for community-acquired complicated intra-abdominal infections in Italy: a retrospective study.
    Dalfino L; Bruno F; Colizza S; Concia E; Novelli A; Rebecchi F; Spandonaro F; Alato C
    World J Emerg Surg; 2014; 9():39. PubMed ID: 25028594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic aspects of pneumococcal pneumonia: a review of the literature.
    De Graeve D; Beutels P
    Pharmacoeconomics; 2004; 22(11):719-40. PubMed ID: 15250750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of gatifloxacin vs ceftriaxone with a macrolide for the treatment of community-acquired pneumonia.
    Dresser LD; Niederman MS; Paladino JA
    Chest; 2001 May; 119(5):1439-48. PubMed ID: 11348951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic utilization and cost analysis in hospitalized patients with community-acquired pneumonia.
    Stein GE; Mantz SL
    Hosp Pharm; 1995 Feb; 30(2):132-4, 137. PubMed ID: 10140526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of ceftriaxone in the treatment of community-acquired pneumonia in adult hospital patients. A pharmaco-economic study based on a meta-analysis.
    Wessels F; Anderson AN; Ebrahim O
    S Afr Med J; 1998 Mar; 88(3):251-5. PubMed ID: 9608289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cost-minimization analysis comparing azithromycin-based and levofloxacin-based protocols for the treatment of patients hospitalized with community-acquired pneumonia: results from the CAP-IN trial.
    Samsa GP; Matchar DB; Harnett J; Wilson J
    Chest; 2005 Nov; 128(5):3246-54. PubMed ID: 16304269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic use in an Italian university hospital.
    Mazzeo F; Capuano A; Motola G; Russo F; Berrino L; Filippelli A; Rossi F
    J Chemother; 2002 Aug; 14(4):332-5. PubMed ID: 12420848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and economic outcomes of empiric parenteral antibiotic therapy for pneumonia: a retrospective study of 1,032 hospitalized patients.
    Bassi O; Zuccarelli S; Amalfitano ME
    J Chemother; 1998 Oct; 10(5):369-74. PubMed ID: 9822354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefotaxime. A pharmacoeconomic review of its use in the treatment of infections.
    Plosker GL; Foster RH; Benfield P
    Pharmacoeconomics; 1998 Jan; 13(1 Pt 1):91-106. PubMed ID: 10175990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and economic outcomes in the treatment of lower respiratory tract infections.
    Brixner DI
    Am J Manag Care; 2004 Oct; 10(12 Suppl):S400-7. PubMed ID: 15603249
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.